My Type 2 Diabetes: Person-centred Health Care (MinT2D)
Primary Purpose
Diabetes Mellitus, Type 2
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Person centred care
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2
Eligibility Criteria
Inclusion Criteria:
• Type 2 diabetes
Exclusion Criteria:
- Unstable cardiovascular disease
- Severe chronic obstructive pulmonary disease (COPD)
Sites / Locations
- Department of Circulation and Medical Imaging, NTNU
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intervention
Control
Arm Description
Baseline testing with blood samples, blood pressure and 6 minute walking test. After answering a comprehensive screening tool questionnaire and a conversation with a resource person about "What is important to you", the study participant will chose one or several of the following interventions: physical activity, nutrition, motivation, health competence, psychosocial.
Baseline testing with blood samples, blood pressure, 6 minute walking test and screening tool questionnaire.
Outcomes
Primary Outcome Measures
Change in HbA1c from baseline until week 12
Glycated haemoglobin (HbA1c) is a measurement of the three-month average blood sugar level and HbA1c is an important outcome measure in diabetes clinical trials.
Secondary Outcome Measures
Change in waist circumference from baseline until week 12
Waist circumference is a simple method to assess abdominal adiposity that is easy to standardize and clinically apply. Waist circumference is strongly associated with all-cause and cardiovascular mortality
Change in physical fitness by the number of PAI from baseline until week 12
PAI (personalized activity index) was derived from an algorithm from one of the world's largest health studies (HUNT) and is a single, easy-to-understand personalized activity tracking metric that can help everyday people manage their health. Maintaining 100 PAI or more per week is strongly associated with adding on average 5 years to your life and reducing the risk of cardiovascular disease mortality by an average of 25%.
Health competence
HLS-Q12 short version of the European Health Literacy Survey Questionnaire (HLS-EU-Q47)
Change in mental health by questionnaire SCL-90r until week 12
The Symptom Checklist-90-R (SCL-90-R) is a relatively brief self-report psychometric instrument (questionnaire) published by the Clinical Assessment division of the Pearson Assessment & Information group. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. SCL-90r is useful in measuring patient progress or treatment outcomes.
Full Information
NCT ID
NCT04935554
First Posted
October 22, 2020
Last Updated
April 12, 2023
Sponsor
Norwegian University of Science and Technology
Collaborators
The Centre for Health Innovation, The Dam Foundation
1. Study Identification
Unique Protocol Identification Number
NCT04935554
Brief Title
My Type 2 Diabetes: Person-centred Health Care
Acronym
MinT2D
Official Title
My Type 2 Diabetes: Person-centred Health Care
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
August 17, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
The Centre for Health Innovation, The Dam Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The T2D project is a research and innovation project that will create a new comprehensive, participant-centered service model for interaction, increased physical activity, self-management, distance monitoring and lifestyle change for patients with type 2 diabetes (T2D). Central to the degree of innovation is a new model for interaction and use of technology for distance monitoring and coping.
Detailed Description
Type 2 diabetes is both physically and mentally stressful. At the same time, it requires a high individual effort, which can be demanding. Good mental health is necessary to be able to manage and control diabetes in a healthy and effective way. Therefore, we want to create an offer that takes care of the whole person, and physically as well as mentally.
Personal follow-up Based on surveys and conversations, the study participant and a contact person will prepare a 12-week plan that will be implemented with self-measurements and follow-up from the contact person. The plan will consist of the activities that best suit the participant's needs. It can be physical activity, diet course, health competence, motivation and psychosocial intervention that will be useful for the participant. After 12 weeks, the implementation will be evaluated.
Several new technological solutions are developed and will be used during the project period. A digital tool for mapping of the individuals needs will be an important part of the survey that is done during start-up. Activity clocks will be used for measuring steps, heart rate, and number of PAI. An online portal for communication and interaction will make information easily accessible to users, simplify distance follow-up and communication flow.
The intervention will take place at two Healthy Life Centres (HLC). A HLC is an interdisciplinary primary health care service which offers effective, knowledge-based measures for people with, or in high risk of disease, who need support in health behaviour change and in coping health problems and chronic disease.
The HLC is part of the public health care service in the municipality. HLC programs have a patient centred approach and aim at strengthening the individual's control of his or her own health.
The intervention study starts in two municipalities in Møre og Romsdal, and the goal is to make the offer national.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Active Comparator
Arm Description
Baseline testing with blood samples, blood pressure and 6 minute walking test. After answering a comprehensive screening tool questionnaire and a conversation with a resource person about "What is important to you", the study participant will chose one or several of the following interventions: physical activity, nutrition, motivation, health competence, psychosocial.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Baseline testing with blood samples, blood pressure, 6 minute walking test and screening tool questionnaire.
Intervention Type
Other
Intervention Name(s)
Person centred care
Intervention Description
physical activity, nutrition, motivation, health competence, psychosocial.
Primary Outcome Measure Information:
Title
Change in HbA1c from baseline until week 12
Description
Glycated haemoglobin (HbA1c) is a measurement of the three-month average blood sugar level and HbA1c is an important outcome measure in diabetes clinical trials.
Time Frame
Baseline and week 12
Secondary Outcome Measure Information:
Title
Change in waist circumference from baseline until week 12
Description
Waist circumference is a simple method to assess abdominal adiposity that is easy to standardize and clinically apply. Waist circumference is strongly associated with all-cause and cardiovascular mortality
Time Frame
Baseline and week 12
Title
Change in physical fitness by the number of PAI from baseline until week 12
Description
PAI (personalized activity index) was derived from an algorithm from one of the world's largest health studies (HUNT) and is a single, easy-to-understand personalized activity tracking metric that can help everyday people manage their health. Maintaining 100 PAI or more per week is strongly associated with adding on average 5 years to your life and reducing the risk of cardiovascular disease mortality by an average of 25%.
Time Frame
Baseline and week 12
Title
Health competence
Description
HLS-Q12 short version of the European Health Literacy Survey Questionnaire (HLS-EU-Q47)
Time Frame
Baseline and week 12
Title
Change in mental health by questionnaire SCL-90r until week 12
Description
The Symptom Checklist-90-R (SCL-90-R) is a relatively brief self-report psychometric instrument (questionnaire) published by the Clinical Assessment division of the Pearson Assessment & Information group. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. SCL-90r is useful in measuring patient progress or treatment outcomes.
Time Frame
Baseline and week 12
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
• Type 2 diabetes
Exclusion Criteria:
Unstable cardiovascular disease
Severe chronic obstructive pulmonary disease (COPD)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charlotte Ingul, PhD
Organizational Affiliation
Norwegian University of Science and Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Circulation and Medical Imaging, NTNU
City
Trondheim
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
My Type 2 Diabetes: Person-centred Health Care
We'll reach out to this number within 24 hrs